Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Episurf Medical

0.03 SEK

+2.68 %

Less than 1K followers

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+2.68 %
-4.06 %
-32.53 %
-59.76 %
-67.06 %
-72.69 %
-97.37 %
-97.06 %
-99.15 %

Episurf Medical operates in the medical technology industry and focuses on the development and manufacture of individually adapted implants for joint repair. The company's products are aimed at surgeons and healthcare institutions. The business is global with a main presence in Europe, North America and Asia. Episurf Medical was founded in 2008 and is headquartered in Stockholm, Sweden.

Read more
Market cap
50.95M SEK
Turnover
142.52K SEK
Revenue
13M
EBIT %
-593.85 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
6.2
2026

Annual report '25

10.4
2026

General meeting '26

24.4
2026

Interim report Q1'26

All
Press releases
3rd party
ShowingAll content types
Press release11/4/2025, 7:45 AM

Episurf's implants market approved in Singapore

Episurf Medical
Regulatory press release11/2/2025, 8:30 PM

Board Member Resigns from the Board of Episurf Medical

Episurf Medical
Press release10/27/2025, 1:20 PM

Redeye: Episurf Medical (Q3 review) - Growing the US customer base

Episurf Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release10/24/2025, 6:30 AM

Episurf: Interim Report 1 January - 30 September 2025

Episurf Medical
Press release10/17/2025, 6:45 AM

Episurf: Scientific article on Episealer® Knee with up to 10 years' follow-up published

Episurf Medical
Press release10/12/2025, 8:00 PM

Board Member Resigns from the Board of Episurf Medical

Episurf Medical
Regulatory press release9/30/2025, 10:15 AM

Change in number of shares and votes in Episurf Medical

Episurf Medical
Regulatory press release9/16/2025, 3:40 PM

New Chief Executive Officer at Episurf Medical

Episurf Medical
Press release9/1/2025, 6:00 AM

Episurf: Episealer® included in the Swedish Knee Arthroplasty Register 2025

Episurf Medical
Regulatory press release8/29/2025, 6:00 AM

Episurf Medical AB changes liquidity provider to Mangold Fondkommission AB

Episurf Medical
Press release8/28/2025, 6:30 PM

Episurf Medical resolves on an issue of units to guarantors in connection with the completed rights issue

Episurf Medical
Press release8/25/2025, 6:30 PM

Episurf Medical announces final outcome of the rights issue

Episurf Medical
Regulatory press release8/22/2025, 3:40 PM

Episurf: Preliminary outcome indicates significantly oversubscribed rights issue

Episurf Medical
Press release8/20/2025, 3:30 PM

Episurf Medical announces interview with CEO

Episurf Medical
Regulatory press release8/5/2025, 10:00 AM

Episurf Medical publishes prospectus in connection with the company's rights issue of units

Episurf Medical
Regulatory press release8/4/2025, 1:15 PM

Summary from the Extraordinary General Meeting of Episurf Medical AB (publ)

Episurf Medical
Regulatory press release8/1/2025, 6:00 AM

The Swedish Securities Council grants exemption from the obligation to submit a mandatory offer in connection with Episurf Medical's rights issue of units

Episurf Medical
Press release7/15/2025, 10:13 AM

Redeye: Episurf Medical Q2 2025 - Negative impact due to ongoing restructuring

Episurf Medical
Regulatory press release7/11/2025, 6:30 AM

Episurf: Interim Report 1 January - 30 June 2025

Episurf Medical
Regulatory press release7/3/2025, 5:30 PM

Notice of Extraordinary General Meeting of Episurf Medical AB (publ)

Episurf Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.